1. Home
  2. PHAR

PHAR

Pharming Group N.V.

Logo Pharming Group N.V.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-23-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

Founded: 1988 Country:
N/A
Employees: N/A City: N/A
Market Cap: 726.0M IPO Year: N/A
Target Price: $37.00 AVG Volume (30 days): 2.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.17 EPS Growth: N/A
52 Week Low/High: $9.70 - $16.71 Next Earning Date: 01-01-0001
Revenue: $272,573,333 Revenue Growth: 19.30%
Revenue Growth (this year): 19.97% Revenue Growth (next year): 14.67%

Share on Social Networks: